Adicet Bio, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001720580-26-000037
- Form type
- 10-Q
- CIK
- 0001720580
- Primary document
- https://www.sec.gov/Archives/edgar/data/1720580/000172058026000037/acet-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Adicet Bio, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-21.6M | - | - |
| Net Income | $-20.2M | - | - |
| Eps Basic | -1.88 | - | - |
| Eps Diluted | -1.88 | - | - |
| Cash And Equivalents | $36.2M | - | - |
| Total Assets | $169.4M | - | - |
| Total Liabilities | $29.3M | - | - |
| Shareholders Equity | $140.1M | - | - |
| Operating Cash Flow | $-21.5M | - | - |
| Capital Expenditures | $37,000 | - | - |